PUBLICATION

Murrangatin suppresses angiogenesis induced by tumor cell-derived media and inhibits AKT activation in zebrafish and endothelial cells

Authors
Long, W., Wang, M., Luo, X., Huang, G., Chen, J.
ID
ZDB-PUB-181006-3
Date
2018
Source
Drug design, development and therapy   12: 3107-3115 (Journal)
Registered Authors
Keywords
AKT, HUVECs, anti-angiogenesis, conditioned medium, murrangatin, zebrafish
MeSH Terms
  • Angiogenesis Inhibitors/chemistry
  • Angiogenesis Inhibitors/isolation & purification
  • Angiogenesis Inhibitors/pharmacology*
  • Animals
  • Biological Products/chemistry
  • Biological Products/isolation & purification
  • Biological Products/pharmacology
  • Cell Movement/drug effects
  • Cell Proliferation/drug effects
  • Cell Survival/drug effects
  • Cells, Cultured
  • Coumarins/chemistry
  • Coumarins/isolation & purification
  • Coumarins/pharmacology*
  • Culture Media, Conditioned/chemistry
  • Culture Media, Conditioned/pharmacology
  • Drug Screening Assays, Antitumor
  • Human Umbilical Vein Endothelial Cells/drug effects*
  • Human Umbilical Vein Endothelial Cells/metabolism
  • Humans
  • Lung Neoplasms/drug therapy*
  • Lung Neoplasms/metabolism
  • Lung Neoplasms/pathology
  • Molecular Conformation
  • Neovascularization, Pathologic/drug therapy*
  • Neovascularization, Pathologic/metabolism
  • Neovascularization, Pathologic/pathology
  • Protein Kinase Inhibitors/chemistry
  • Protein Kinase Inhibitors/isolation & purification
  • Protein Kinase Inhibitors/pharmacology*
  • Proto-Oncogene Proteins c-akt/antagonists & inhibitors*
  • Proto-Oncogene Proteins c-akt/metabolism
  • Signal Transduction/drug effects
  • Structure-Activity Relationship
  • Zebrafish/embryology
PubMed
30288018 Full text @ Drug Des Devel Ther
Abstract
Lung cancer is a major cancer type and a leading cause of cancer-related death. Angiogenesis plays a crucial role in lung cancer pathogenesis and its inhibition is beneficial to patients.
Murrangatin, a natural product, can inhibit the proliferation of lung cancer cells, so herein we investigated its anti-angiogenic effects in transgenic zebrafish TG (fli1: EGFP) and in lung cancer cell-induced angiogenesis in human umbilical vein endothelial cells.
We found that murrangatin strongly inhibited the growth of subintestinal vessels in zebrafish embryos and tumor conditioned media-induced angiogenic phenotypes including cell proliferation, cell invasion, cell migration, and tube formation. Additionally, murrangatin greatly attenuated conditioned medium-induced AKT phosphorylation, but not extracellular signal-regulated kinase 1/2 phosphorylation.
These findings indicate that murrangatin can inhibit tumor-induced angiogensis, at least in part through the regulation of AKT signaling pathways. Murrangatin may, therefore, be a potential candidate for the development of new anti-lung-cancer drugs.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping